Phase I – Other

1,064 trials 249 recruiting

Filter these 1,064 trials by condition, country, sponsor and more.

Open in Search →

A Study to Learn About the Taste Profiles of Different Suspensions of Study Medicine Called PF-07923568 in Healthy Adult Participants Ended

2023-504924-24-00 RSV (respiratory syncytial virus) 2023-07-25
A Phase I study to evaluate the Pharmacokinetics and Safety of Letrozole LEBE in Healthy Post-menopausal Women. Ended

2023-503948-13-00 Healthy Post-menopausal women. 2023-07-20
A study to characterize the pharmacokinetic profile of norucholic acid (NCA) in patients with primary sclerosing cholangitis (PSC) Ended

2023-507027-37-00 Primary Sclerosing Cholangitis (PSC) 2023-07-20
A study investigating the absorption and food effect of different tablet formulations of JNJ-77242113, a new compound in the treatment of in… Ended

2023-504720-26-00 Inflammatory Conditions 2023-07-19
A study to test how kidney problems influence the blood concentrations of efgartigimod Ended

2023-503992-88-00 renal impairment 2023-07-14
An open-label, single-dose phase 1 study to evaluate the Absorption, Metabolism, and Excretion of [14C]-AZ-3102 in Healthy Male Subjects Ended

2023-504916-14-00 Glycosphingolipid lysosomal storage disorders 2023-07-13
A study to learn how safe the study drug BAY 2416964 (AhR inhibitor) in combination with the treatment pembrolizumab is, how this combinatio… Ended

2023-503547-33-00 Advanced solid tumors 2023-07-12
Physiologically based pharmacokinetic modelling of oral and intranasal formulations of zolmitriptan in healthy volunteers Ended

2023-504492-24-00 healthy 2023-07-12
A clinical study of MK-6552 in healthy adults (MK-6552-002) Ended

2023-504954-37-00 Narcolepsy 2023-07-07
A Phase 1, Open-Label, Single-Dose Study To Evaluate The Pharmacokinetics Of Mavodelpar In Subjects With Impaired Hepatic Function Ended

2023-504007-91-00 Impaired Hepatic Function The study will enroll as foll 2023-07-06
A PHASE 1 STUDY TO ASSESS THE MASS BALANCE, PHARMACOKINETICS, AND METABOLISM OF ORAL [14C]-ZIPALERTINIB IN HEALTHY ADULT MALE SUBJECTS Ended

2023-505085-28-00 Cancer 2023-07-05
CC-122 Rollover Study Ended

2022-501855-97-00 Multiple Myeloma, Follicular Lymphoma, Diffuse Large B- 2023-06-29
Drug-Drug Interaction Study With AGMB-129 and Midazolam in Healthy Participants Ended

2023-504461-23-00 Fibrostenotic Crohn’s disease 2023-06-26
A Phase I, Single-Centre, Double-Blind, Randomized, Placebo-Controlled Clinical Trial To Determine Urinary Xylose Cut-Off Point For The Diag… Ended

2023-504232-18-00 Hypolactasia 2023-06-22
A study to test how well different doses of BI 1815368 are tolerated by healthy men Ended

2023-503815-13-00 Healthy 2023-06-19
Randomized, double-blind, placebo-controlled study assessing the safety, tolerability, pharmacokinetics and pharmacodynamics of pitolisant a… Ended

2023-503945-78-00 Narcolepsy with cataplexy 2023-06-13
A clinical trial in healthy people to look at how the body processes RO7268489 over time and when taken before or after a meal Ended

2023-503528-25-00 There is no medical condition being investigated. This 2023-06-09
A Study to Investigate the Effect of Hepatic Impairment on the Pharmacokinetics, Safety and Tolerability of Camizestrant in Post-menopausal … Ended

2022-502277-41-00 moderate or severe hepatic impairment 2023-06-05
Open label, Phase I study to assess and compare the pharmacokinetic parameters after multiple oral administration of stiripentol 1000 mg in … Ended

2024-516655-40-00 Patients with renal impairement 2023-06-02
A Study to Learn About the Study Medicine Called Nirmatrelvir/Ritonavir in People Who are Healthy Volunteers Co-administered the Medicine Ro… Ended

2023-503570-20-00 coronavirus disease 2019 (COVID-19) 2023-06-02
A randomized, double-blind, single-center, 2-period cross-over Phase I study to assess the tolerability, safety and pharmacokinetics of anti… Ended

2023-503971-45-00 Depression 2023-06-01
A Phase 1b, 2-part, placebo-controlled study to evaluate the efficacy, safety, and PK of PF-07054894 in participants with mild to severe UC. Ended

2022-501047-32-00 ULCERATIVE COLITIS 2023-05-30
A Double-Blind Placebo-Controlled Randomised Phase 1b Study of the Pharmacokinetics of ALE.F02 in Patients with Advanced Liver Fibrosis and/… Ended

2024-516455-40-00 Advanced liver fibrosis and/or mild liver cirrhosis 2023-05-25
A Phase 1, Multicentre, Open-Label Study to Evaluate the Pharmacokinetics, Safety, and Tolerability of a Single IV Dose of Rezafungin Acetat… Ended

2022-501985-23-00 Fungal infections 2023-05-18